Xuxu Gou

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Proteogenomic Markers of Chemotherapy Resistance and Response in Triple-Negative Breast Cancer”.

Proteogenomic Markers of Chemotherapy Resistance and Response in Triple-Negative Breast Cancer

Cancer Discovery(2022)10.1158/2159-8290.cd-22-0200

N/A

2.5DataRank · unranked

140 citations

Eric J. Jaehnig, Karsten Krug, Jonathan T. Lei, Erik J. Bergstrom, Beom-Jun Kim +34 more

Transcriptional Reprogramming Differentiates Active from Inactive ESR1 Fusions in Endocrine Therapy-Refractory Metastatic Breast Cancer

Cancer Research(2021)10.1158/0008-5472.can-21-1256

N/A

0.483DataRank · unranked

24 citations

Meenakshi Anurag, Jonathan T. Lei, Beom‐Jun Kim, Purba Singh, Sinem Şeker +16 more

PKMYT1 Is a Marker of Treatment Response and a Therapeutic Target for CDK4/6 Inhibitor-Resistance in ER+ Breast Cancer

Molecular Cancer Therapeutics(2024)10.1158/1535-7163.mct-23-0564

N/A

0.470DataRank · unranked

22 citations

Beom-Jun Kim, Aparna Mitra, Craig T. Vollert, Jonathan T. Lei, Diana Fandino +18 more

De novo design of drug-binding proteins with predictable binding energy and specificity

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.12.23.573178

N/A

0.208DataRank · unranked

3 citations

Xuxu Gou, Sophia K. Tan, Samuel I. Mann, Hyunjun Yang, Xiaofang Zhong +9 more

Identification of a Two-Gene Biomarker Correlated with Sensitivity to Combined PARP7 Inhibition and AHR Activation in Cancer Cells

Cancer Research Communications(2025)10.1158/2767-9764.crc-25-0173

N/A

0DataRank · unranked

0 citations

Huadong Chen, Morgan E. Diolaiti, Alan Ashworth, Xuxu Gou

Kinome Reprogramming Is a Targetable Vulnerability in ESR1 Fusion-Driven Breast Cancer

Cancer Research(2023)10.1158/0008-5472.can-22-3484

N/A

0DataRank · unranked

12 citations

Beom-Jun Kim, Meenakshi Anurag, Jonathan T. Lei, Meggie N. Young, Matthew V. Holt +11 more

De novo design of drug-binding proteins with predictable binding energy and specificity

Science(2024)10.1126/science.adl5364

N/A

0DataRank · unranked

69 citations

Xuxu Gou, Sophia K. Tan, Samuel I. Mann, Hyunjun Yang, Xiaofang Zhong +9 more

PARP7 Inhibitors and AHR Agonists Act Synergistically across a Wide Range of Cancer Models

Molecular Cancer Therapeutics(2024)10.1158/1535-7163.mct-24-0211

N/A

0DataRank · unranked

12 citations

Xuxu Gou, Ying Mao, Patrick C. O’Leary, Morgan E. Diolaiti, Alan Ashworth +1 more